Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Depreciation & Amortization - Total (2021 - 2025)

AdaptHealth (AHCO) has 5 years of Depreciation & Amortization - Total data on record, last reported at $92.5 million in Q4 2025.

  • For Q4 2025, Depreciation & Amortization - Total rose 8.82% year-over-year to $92.5 million; the TTM value through Dec 2025 reached $361.6 million, up 5.39%, while the annual FY2025 figure was $361.6 million, 5.39% up from the prior year.
  • Depreciation & Amortization - Total reached $92.5 million in Q4 2025 per AHCO's latest filing, roughly flat from $92.7 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $92.7 million in Q3 2025 and bottomed at $36.9 million in Q1 2021.
  • Average Depreciation & Amortization - Total over 5 years is $78.9 million, with a median of $85.4 million recorded in 2024.
  • Peak YoY movement for Depreciation & Amortization - Total: surged 81.84% in 2022, then decreased 5.96% in 2023.
  • A 5-year view of Depreciation & Amortization - Total shows it stood at $65.0 million in 2021, then soared by 42.0% to $92.3 million in 2022, then fell by 5.96% to $86.8 million in 2023, then dropped by 2.07% to $85.0 million in 2024, then increased by 8.82% to $92.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization - Total were $92.5 million in Q4 2025, $92.7 million in Q3 2025, and $87.2 million in Q2 2025.